Randomized phase 3 study of lenalidomide versus chlorambucil as first-line therapy for older patients with chronic lymphocytic leukemia (the ORIGIN trial)

A. Chanan-Khan, M. Egyed, T. Robak, F. A. Martinelli De Oliveira, M. A. Echeveste, S. Dolan, P. Desjardins, J. Z. Blonski, J. Mei, N. Golany, J. Zhang, J. G. Gribben

Research output: Contribution to journal › Letter › peer-review

22 Scopus citations

Fingerprint

Dive into the research topics of 'Randomized phase 3 study of lenalidomide versus chlorambucil as first-line therapy for older patients with chronic lymphocytic leukemia (the ORIGIN trial)'. Together they form a unique fingerprint.